Jellagen Pty Ltd is a Med-Tech business manufacturing next generation collagen products sourced from Jellyfish for application in 2D and 3D cell culture and medical devices. Jellagen’s research grade materials are commercialised with distributors supporting sales into the global cell culture and stem cell research markets. Jellagen’s collagen products offers the potential of in vitro to in vivo applications as well as batch to batch consistency offering advantages to research and medical applications. Jellagen products enable the researcher to optimise their study through providing an effective starting material for culturing cells which decrease downtime and allow for more effective representation of human model.
Jellagen is aiming to produce ISO13485 certified medical grade collagen products in 2017 for bulk OEM opportunities for medical devices and clinical applications. Jellagen also conducts in-house research and development of new collagen technologies to support fabrication of new medical devices offering new approaches to wound management and tissue engineering.